Top Five Radiology Content — February 2025
Catch up on the most-well viewed radiology content in February 2025.
Touching on a variety of topics in radiology, ranging from a projection of imaging volume increases and radiologist shortages for the next 30 years to a comparative study of artificial intelligence (AI) software for large vessel occlusion (LVO) detection on CT scans and a new meta-analysis on PET/CT radiotracers for clinically significant prostate cancer (csPCa), here are the top five most well-viewed content for February 2025.
The Reading Room Podcast: Current Perspectives on the Updated Appropriate Use Criteria for Brain PET
March 18th 2025In a new podcast, Satoshi Minoshima, M.D., Ph.D., and James Williams, Ph.D., share their insights on the recently updated appropriate use criteria for amyloid PET and tau PET in patients with mild cognitive impairment.
Expanded FDA Approval Allows Use of Pluvicto Prior to Chemotherapy in Patients with mCRPC
March 28th 2025Recent research demonstrated a 59 percent reduced risk of progression or death with the radioligand therapy Pluvicto in comparison to a change of androgen receptor pathway inhibitor (ARPI) for patients with metastatic castration-resistant prostate cancer (mCRPC).
GE HealthCare Launches PET MPI Agent Flyrcado at ACC Conference
March 28th 2025The positron emission tomography myocardial perfusion imaging (PET MPI) agent, which offers a significantly higher half-life than other cardiac PET agents, was recently granted pass-through payment status by CMS that will go into effect on April 1, 2025.
